\-\ Texto\\:\\ \ \(0\)\
\-\ resp\\:\\ r\\ side\\ cta\\,\\ l\\ side\\ with\\ decreased\\ bs\\ and\\ egophany\\ over\\ lower\\ \\?\\ of\\ lung\\.\ \(0\)\
\-\ cvs\\:\\ rrr\\ without\\ r\\/g\\/m\\ \\ \\ \\ \\ extr\\:\\ no\\ c\\/c\\/e\\ \\ \ \(0\)\
\-\ wbc\\ 11\\.4\\,\\ h\\/h\\ 11\\.1\\/34\\,\\ plt\\ 548\ \(0\)\
\-\ 136\\/4\\.8\\/98\\/27\\/12\\/0\\.6\\/106\\ \\ ca\\ 8\\.4\\ \\ alb\\ 2\\.7\\ \\ \\ mg\\ 2\\.2\ \(0\)\
\-\ likely\\ treatment\\ will\\ consist\\ of\\ chemotherapy\\ and\\ radiation\\.\\ there\\ was\\ and\\ currently\\ is\\ discussion\\ of\\ performing\\ vats\\ in\\ this\\ case\\ for\\ further\\ staging\\ and\\ potential\\ treatment\\.\ \(0\)\
\-\ lul\\ mass\\,\\ tracheal\\ deviation\ \(0\)\
\-\ l\\ sided\\ pleural\\ effusion\ \(0\)\
\-\ fissure\\ present\\ as\\ an\\ edge\\ on\\ lateral\\ cxr\ \(0\)\
\-\ spine\\ sign\\ on\\ lateral\\ cxr\ \(0\)\
\-\ indistinct\\ lv\\ heart\\ border\\ on\\ lateral\\ cxr\ \(0\)\
\-\ mass\\ on\\ ct\\ abutting\\ mediastinum\ \(0\)\
\-\ stage\\ iiib\\ adenocarcinoma\ \(0\)\
\-\ lung\\ cancer\ \(74\)\
\-\ granulomatous\\ disease\ \(29\)\
\-\ benign\\ mass\ \(2\)\
\-\ other\\ inflammation\\ \\(pneumonia\\)\ \(0\)\
\-\ congenital\\ abnormality\ \(6\)\
\-\ 56\\ yo\\ female\\ presents\\ for\\ screening\\ x\\-ray\\.\\ she\\ is\\ aymptomatic\\ except\\ for\\ a\\ mild\\ cough\\ and\\ slight\\ \\ fatigue\\ for\\ about\\ one\\ month\\.\ \(0\)\
\-\ adenocarcinoma\\ is\\ the\\ most\\ common\\ form\\ of\\ lung\\ cancer\\ in\\ the\\ us\\.\\ it\\ is\\ associated\\ with\\ smoking\\ although\\ this\\ less\\ strongly\\ than\\ other\\ types\\ of\\ lung\\ cancer\\.\\ adenocarcinomas\\ typically\\ are\\ well\\-defined\\ masses\\ that\\ occur\\ in\\ a\\ peripheral\\ location\\.\\ this\\ type\\ of\\ lung\\ cancer\\ \\ is\\ more\\ common\\ in\\ women\\,\\ usually\\ occurring\\ in\\ current\\ or\\ former\\ smokers\\ although\\ occasionally\\ occurring\\ in\\ non\\-smokers\\.\\ \\ staging\\ involves\\ the\\ tmn\\ system\\ with\\ this\\ patient\\ at\\ stage\\ iiib\\ based\\ on\\ a\\ t4nomo\\ lesion\\ \\(5\\ cm\\ in\\ size\\ with\\ mediastinal\\ invasion\\)\\.\\ \\ \\ surgery\\ is\\ the\\ treatment\\ of\\ choice\\ for\\ stage\\ i\\ and\\ ii\\ lung\\ adenocarcinoma\\.\\ stage\\ iii\\ and\\ iv\\ adenocarcinoma\\ is\\ usually\\ treated\\ with\\ chemotherapy\\ and\\ radiation\\ although\\ there\\ select\\ stage\\ iii\\ and\\ iv\\ cancers\\ may\\ be\\ amenable\\ to\\ surgical\\ treatment\\.\\ \\ median\\ survival\\ for\\ stage\\ iiib\\ lung\\ cancer\\ is\\ 12\\ months\\ and\\ 5\\-year\\ surival\\ is\\ less\\ than\\ 5\\%\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stage\\:\\ 0\\.07388583301881783\ \(0\)\
\-\ iiib\\:\\ 0\\.0682710494826351\ \(0\)\
\-\ lung\\:\\ 0\\.05853416838402441\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.04988587087247621\ \(0\)\
\-\ cancer\\:\\ 0\\.04745211595210753\ \(0\)\
\-\ cxr\\:\\ 0\\.03654762436951092\ \(0\)\
\-\ staging\\:\\ 0\\.03326823058010724\ \(0\)\
\-\ occurring\\:\\ 0\\.03224639970359425\ \(0\)\
\-\ egophany\\:\\ 0\\.029782156837724658\ \(0\)\
\-\ 11\\.1\\/34\\:\\ 0\\.029782156837724658\ \(0\)\
\-\ 548\\:\\ 0\\.029782156837724658\ \(0\)\
\-\ 136\\/4\\.8\\/98\\/27\\/12\\/0\\.6\\/106\\:\\ 0\\.029782156837724658\ \(0\)\
\-\ aymptomatic\\:\\ 0\\.029782156837724658\ \(0\)\
\-\ t4nomo\\:\\ 0\\.029782156837724658\ \(0\)\
\-\ surival\\:\\ 0\\.029782156837724658\ \(0\)\
\-\ although\\:\\ 0\\.0292492832490872\ \(0\)\
\-\ r\\/g\\/m\\:\\ 0\\.027440443389887003\ \(0\)\
\-\ non\\-smokers\\:\\ 0\\.027440443389887003\ \(0\)\
\-\ tmn\\:\\ 0\\.027440443389887003\ \(0\)\
\-\ iii\\:\\ 0\\.02710471202184623\ \(0\)\
\-\ l\\:\\ 0\\.026321199311745768\ \(0\)\
\-\ cvs\\:\\ 0\\.025098729942049352\ \(0\)\
\-\ extr\\:\\ 0\\.02434486659301486\ \(0\)\
\-\ adenocarcinomas\\:\\ 0\\.02434486659301486\ \(0\)\
\-\ 11\\.4\\:\\ 0\\.023728915387629876\ \(0\)\
\-\ treatment\\:\\ 0\\.023373202156768746\ \(0\)\
\-\ c\\/c\\/e\\:\\ 0\\.023208136063889138\ \(0\)\
\-\ select\\:\\ 0\\.023208136063889138\ \(0\)\
\-\ amenable\\:\\ 0\\.022757016494211697\ \(0\)\
\-\ smokers\\:\\ 0\\.0223591008332104\ \(0\)\
\-\ vats\\:\\ 0\\.022003153145177205\ \(0\)\
\-\ alb\\:\\ 0\\.02138720193979222\ \(0\)\
\-\ 8\\.4\\:\\ 0\\.021116787386841085\ \(0\)\
\-\ lul\\:\\ 0\\.021116787386841085\ \(0\)\
\-\ 5\\-year\\:\\ 0\\.021116787386841085\ \(0\)\
\-\ iv\\:\\ 0\\.021070438766629014\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02069557962933017\ \(0\)\
\-\ lv\\:\\ 0\\.020415303046374043\ \(0\)\
\-\ former\\:\\ 0\\.020415303046374043\ \(0\)\
\-\ h\\/h\\:\\ 0\\.020210490134832036\ \(0\)\
\-\ side\\:\\ 0\\.02000301690381129\ \(0\)\
\-\ less\\:\\ 0\\.019553648677855962\ \(0\)\
\-\ resp\\:\\ 0\\.01949660806163201\ \(0\)\
\-\ abutting\\:\\ 0\\.019339445846649265\ \(0\)\
\-\ 2\\.7\\:\\ 0\\.01918927097309915\ \(0\)\
\-\ 2\\.2\\:\\ 0\\.01904548849195457\ \(0\)\
\-\ radiation\\:\\ 0\\.018947643578123896\ \(0\)\
\-\ indistinct\\:\\ 0\\.01890757634830506\ \(0\)\
\-\ lateral\\:\\ 0\\.018716230192140713\ \(0\)\
\-\ consist\\:\\ 0\\.018647572830953276\ \(0\)\
\-\ plt\\:\\ 0\\.018406157412094677\ \(0\)\
\-\ performing\\:\\ 0\\.018406157412094677\ \(0\)\
\-\ bs\\:\\ 0\\.01818084871446403\ \(0\)\
\-\ tracheal\\:\\ 0\\.01777084581917934\ \(0\)\
\-\ usually\\:\\ 0\\.01753329901261324\ \(0\)\
\-\ cancers\\:\\ 0\\.01740525938458396\ \(0\)\
\-\ is\\:\\ 0\\.01709667907250855\ \(0\)\
\-\ 5\\:\\ 0\\.016892975827325428\ \(0\)\
\-\ median\\:\\ 0\\.01670377504411692\ \(0\)\
\-\ edge\\:\\ 0\\.016182995720376177\ \(0\)\
\-\ deviation\\:\\ 0\\.016123199851797124\ \(0\)\
\-\ strongly\\:\\ 0\\.016064443964257026\ \(0\)\
\-\ mg\\:\\ 0\\.015839135266626374\ \(0\)\
\-\ fissure\\:\\ 0\\.015477742970842024\ \(0\)\
\-\ survival\\:\\ 0\\.015477742970842024\ \(0\)\
\-\ fatigue\\:\\ 0\\.015429132371341686\ \(0\)\
\-\ 56\\:\\ 0\\.015196048346047934\ \(0\)\
\-\ occasionally\\:\\ 0\\.015196048346047934\ \(0\)\
\-\ than\\:\\ 0\\.015128708479177527\ \(0\)\
\-\ common\\:\\ 0\\.015109913594299982\ \(0\)\
\-\ cta\\:\\ 0\\.015063545936746307\ \(0\)\
\-\ choice\\:\\ 0\\.014936044828696147\ \(0\)\
\-\ well\\-defined\\:\\ 0\\.014853641270844258\ \(0\)\
\-\ for\\:\\ 0\\.014779219229244226\ \(0\)\
\-\ rrr\\:\\ 0\\.014733686242273615\ \(0\)\
\-\ types\\:\\ 0\\.014733686242273615\ \(0\)\
\-\ except\\:\\ 0\\.01461784477781878\ \(0\)\
\-\ smoking\\:\\ 0\\.014580097140662952\ \(0\)\
\-\ women\\:\\ 0\\.014027295033291998\ \(0\)\
\-\ granulomatous\\:\\ 0\\.013933008586950523\ \(0\)\
\-\ potential\\:\\ 0\\.013902155601939466\ \(0\)\
\-\ mediastinum\\:\\ 0\\.013902155601939466\ \(0\)\
\-\ invasion\\:\\ 0\\.013902155601939466\ \(0\)\
\-\ border\\:\\ 0\\.013751980728389353\ \(0\)\
\-\ slight\\:\\ 0\\.01358016175124918\ \(0\)\
\-\ discussion\\:\\ 0\\.013524777258763786\ \(0\)\
\-\ current\\:\\ 0\\.013524777258763786\ \(0\)\
\-\ form\\:\\ 0\\.013497421818788722\ \(0\)\
\-\ ca\\:\\ 0\\.013443366611537232\ \(0\)\
\-\ involves\\:\\ 0\\.0134166599240132\ \(0\)\
\-\ other\\:\\ 0\\.013308368572313843\ \(0\)\
\-\ r\\:\\ 0\\.013111636793364212\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.013015789843603348\ \(0\)\
\-\ this\\:\\ 0\\.012988340720461258\ \(0\)\
\-\ ii\\:\\ 0\\.012451417935957517\ \(0\)\
\-\ screening\\:\\ 0\\.012314305503136306\ \(0\)\
\-\ inflammation\\:\\ 0\\.012276131329981127\ \(0\)\
\-\ mediastinal\\:\\ 0\\.012257204790965348\ \(0\)\
\-\ on\\:\\ 0\\.012227888722388988\ \(0\)\
\-\ us\\:\\ 0\\.012109492591594296\ \(0\)\
\-\ mass\\:\\ 0\\.012045212908252344\ \(0\)\
\-\ pneumonia\\:\\ 0\\.011933495591988209\ \(0\)\
\-\ i\\:\\ 0\\.011933495591988209\ \(0\)\
\-\ 12\\:\\ 0\\.011815535236899601\ \(0\)\
\-\ \\:\\:\\ 0\\.01145548799990539\ \(0\)\
\-\ currently\\:\\ 0\\.011439772956121816\ \(0\)\
\-\ system\\:\\ 0\\.011366486386489181\ \(0\)\
\-\ \\?\\:\\ 0\\.011266484799407117\ \(0\)\
\-\ pleural\\:\\ 0\\.01121064256308546\ \(0\)\
\-\ about\\:\\ 0\\.011128572655757608\ \(0\)\
\-\ cough\\:\\ 0\\.011061671887865108\ \(0\)\
\-\ based\\:\\ 0\\.011009089061712706\ \(0\)\
\-\ effusion\\:\\ 0\\.010970182162856086\ \(0\)\
\-\ occur\\:\\ 0\\.010831238610748441\ \(0\)\
\-\ sided\\:\\ 0\\.010674076395765696\ \(0\)\
\-\ abnormality\\:\\ 0\\.010650533594022137\ \(0\)\
\-\ congenital\\:\\ 0\\.010557969492035264\ \(0\)\
\-\ wbc\\:\\ 0\\.010523901522215582\ \(0\)\
\-\ peripheral\\:\\ 0\\.010445720682480127\ \(0\)\
\-\ typically\\:\\ 0\\.01019062759968234\ \(0\)\
\-\ location\\:\\ 0\\.010069958401702342\ \(0\)\
\-\ heart\\:\\ 0\\.01003067448955667\ \(0\)\
\-\ sign\\:\\ 0\\.010001508451905646\ \(0\)\
\-\ in\\:\\ 0\\.009965475037100624\ \(0\)\
\-\ benign\\:\\ 0\\.009963007996733789\ \(0\)\
\-\ masses\\:\\ 0\\.009758758101338133\ \(0\)\
\-\ type\\:\\ 0\\.009731838609280103\ \(0\)\
\-\ size\\:\\ 0\\.009678634700603959\ \(0\)\
\-\ spine\\:\\ 0\\.009507106574342393\ \(0\)\
\-\ further\\:\\ 0\\.009180554533108981\ \(0\)\
\-\ will\\:\\ 0\\.009032030467497102\ \(0\)\
\-\ yo\\:\\ 0\\.008686998389536358\ \(0\)\
\-\ month\\:\\ 0\\.008660859935137195\ \(0\)\
\-\ treated\\:\\ 0\\.008641387959742768\ \(0\)\
\-\ there\\:\\ 0\\.008592672678817491\ \(0\)\
\-\ decreased\\:\\ 0\\.00858363649569108\ \(0\)\
\-\ likely\\:\\ 0\\.008142871506539381\ \(0\)\
\-\ she\\:\\ 0\\.008104007234642474\ \(0\)\
\-\ months\\:\\ 0\\.007884936806385363\ \(0\)\
\-\ one\\:\\ 0\\.007823416835508933\ \(0\)\
\-\ cm\\:\\ 0\\.0077430949926249526\ \(0\)\
\-\ mild\\:\\ 0\\.00760220761463222\ \(0\)\
\-\ over\\:\\ 0\\.007350143885607982\ \(0\)\
\-\ more\\:\\ 0\\.007220190234162724\ \(0\)\
\-\ surgery\\:\\ 0\\.0070101319741901185\ \(0\)\
\-\ associated\\:\\ 0\\.006812373519958453\ \(0\)\
\-\ without\\:\\ 0\\.006797341778237028\ \(0\)\
\-\ \\%\\:\\ 0\\.006734192680222999\ \(0\)\
\-\ most\\:\\ 0\\.006664983586919177\ \(0\)\
\-\ present\\:\\ 0\\.006520299844363787\ \(0\)\
\-\ lower\\:\\ 0\\.006492777261364401\ \(0\)\
\-\ it\\:\\ 0\\.006489352650449381\ \(0\)\
\-\ may\\:\\ 0\\.006332190435466635\ \(0\)\
\-\ case\\:\\ 0\\.006315893354281321\ \(0\)\
\-\ and\\:\\ 0\\.006081385328791164\ \(0\)\
\-\ surgical\\:\\ 0\\.006068316791390046\ \(0\)\
\-\ female\\:\\ 0\\.005935000917053492\ \(0\)\
\-\ presents\\:\\ 0\\.005897446944283534\ \(0\)\
\-\ lesion\\:\\ 0\\.005880254141893428\ \(0\)\
\-\ that\\:\\ 0\\.0049864213802662954\ \(0\)\
\-\ \\(\\:\\ 0\\.0048808224746206795\ \(0\)\
\-\ \\)\\:\\ 0\\.004821200622387197\ \(0\)\
\-\ disease\\:\\ 0\\.004718707909512514\ \(0\)\
\-\ \\,\\:\\ 0\\.00457280516076499\ \(0\)\
\-\ be\\:\\ 0\\.004451880822107869\ \(0\)\
\-\ as\\:\\ 0\\.0043668158982909724\ \(0\)\
\-\ ct\\:\\ 0\\.004038188018216361\ \(0\)\
\-\ a\\:\\ 0\\.004019592585999337\ \(0\)\
\-\ an\\:\\ 0\\.003992111027988953\ \(0\)\
\-\ are\\:\\ 0\\.003935384704491898\ \(0\)\
\-\ at\\:\\ 0\\.003911362002809571\ \(0\)\
\-\ or\\:\\ 0\\.003383522800553066\ \(0\)\
\-\ was\\:\\ 0\\.003338775412884077\ \(0\)\
\-\ no\\:\\ 0\\.0029069059145398718\ \(0\)\
\-\ patient\\:\\ 0\\.0028938916585013108\ \(0\)\
\-\ of\\:\\ 0\\.0027551574513037806\ \(0\)\
\-\ with\\:\\ 0\\.0019764218934102996\ \(0\)\
\-\ the\\:\\ 0\\.0018682335770760243\ \(0\)\
\-\ \\.\\:\\ 0\\.0015591012475185866\ \(0\)\
\-\ to\\:\\ 0\\.0014427976636587373\ \(0\)\
